Bayer Technology Services acquires Zeptosens

Published: 24-Mar-2005

Bayer Technology Services (BTS) is strengthening its expertise in the field of highly sensitive detection processes for life sciences with the acquisition of the business and assets of Zeptosens, Witterswil, Switzerland.


Bayer Technology Services (BTS) is strengthening its expertise in the field of highly sensitive detection processes for life sciences with the acquisition of the business and assets of Zeptosens, Witterswil, Switzerland.

Zeptosens was established 1998 as a spin-off from Novartis. The company's core business is the development, production and sale of a highly sensitive chip system based on fluorescence detection on the surface of a planar optical waveguide. Its commercialized protein and nucleic acid (DNA/RNA) microarrays are used by both the pharmaceutical industry and universities for genome and proteome research.

'The know-how and intellectual property of Zeptosens are an excellent complement to BTS' existing technology portfolio for planar waveguides and biochip technologies. With this acquisition, BTS can significantly expand its technological basis for the development of innovative applications,' said Dr. Helmut Mothes, senior vice president of process technology at Bayer Technology Services.

In addition to applications within the Bayer group, BTS wants to develop new opportunities with market potential, such as the quality control of food products. BTS plans to refine the technologies and products within its own business strategy, building on them to tap the full potential of planar waveguide technology in the longer term.

Bayer Technology Systems GmbH offers fully-integrated solutions along the life cycle of chemical/pharmaceutical plants, from development through engineering, and construction to process optimization for existing plants.

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now